Astrana Health, Inc.

ASTHNASDAQHealthcare● Active

$38.05

+$0.06(+0.16%)

Market Cap$1.9B

P/E Ratio—

52W High$39.93

52W Low$18.08

Avg Volume447K

Open$37.99

Beta0.94

Free Cash Flow Financials Revenue

Astrana Health, Inc. (ASTH) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

ASTH · free cash flow · updated Jun 8, 2026

Core FCF metrics

ASTH · FCF · TTM · margin & CAGR

Free cash flow was $104.5M for FY2025 (fiscal year ending 2025-12-31), up 136.6% year-over-year The FCF margin was 3.3%. Five-year CAGR stands at +18.4%.

FY2025 Free Cash Flow$104.5M▲ +136.6% YoY

Trailing 12M (TTM)$155.0Mtrailing 4 quarters sum

FCF Margin3.3%$104.5M ÷ revenue

3-Year CAGR+20.9%FY2022 → FY2025

5-Year CAGR+18.4%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

ASTH · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$114.6M(10M)$104.5M▲ +136.6%3.3%

FY2024$52.2M(8M)$44.2M▲ +11.3%2.2%

FY2023$68.2M(29M)$39.7M▼ 32.9%2.9%

FY2022$82.1M(23M)$59.2M▲ +15.8%5.2%

FY2021$70.3M(19M)$51.1M▲ +13.6%6.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

ASTH · P/FCF · FCF yield · FCF per share

Astrana Health, Inc. (ASTH) trades at a FCF yield of 8.24% and a price-to-free-cash-flow ratio of 12.0x. FCF per share stands at $3.16, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

8.24%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$3.16

TTM FCF ÷ Shares Outstanding

Price / FCF

x12.0

Share Price ÷ FCF per Share

EV / FCF (TTM)

x15.9

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

ASTH · cash flow statement · operating / investing / financing

For FY2025, Astrana Health, Inc. generated $114.6M in operating cash flow and spent 10M in capital expenditures, yielding $104.5M in free cash flow.

Operating Activities

+$114.6M

Cash from core business operations

2025-12-31

Investing Activities

−$539.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$569.3M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($114.6M) − |CapEx| (10M) = FCF ($104.5M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

ASTH vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Astrana Health, Inc.YOU

ASTH

$104.5M+136.6%3.3%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Astrana Health, Inc. (ASTH) reported free cash flow of $104.5M for FY2025 (fiscal year ending 2025-12-31), up 136.6% year-over-year. The FCF margin was 3.3%.

Based on available data, Astrana Health, Inc. has maintained positive free cash flow for at least 9 fiscal year(s). FCF peaked at $104.5M in FY2025. The 5-year CAGR stands at +18.4%.

Astrana Health, Inc.'s FCF yield is 8.24% and price-to-FCF ratio is 12.0x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

ASTH free cash flow · 8 questions

Astrana Health, Inc. free cash flow was $104.5M for FY2025, up 136.6% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $155.0M.

ASTH free cash flowASTH FCFASTH FCF 2025ASTH free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Astrana Health, Inc. · Astrana Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026